DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Kepivance (Palifermin) - Current Clinical Trials

 
 



Kepivance Related Clinical Trials

Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma [Completed]

Palifermin DDI (Drug Drug Interaction) [Completed]

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma [Completed]

Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer [Active, not recruiting]

Palifermin After Haploidentical PBSCT [Withdrawn]

Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC) [Completed]

Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant [Withdrawn]

Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE) [Completed]

Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer [Completed]

Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [Completed]

Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation [Completed]

Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support [Completed]

Effectiveness of Palifermin in Increasing CD4 Counts in Treatment-Experienced HIV Infected Adults [Completed]

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy [Withdrawn]

Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis [Recruiting]

Palifermin for Patients Receiving Hematopoietic Stem Cell Transplantation [Not yet recruiting]

Study to Characterize the Effect of Heparin on Palifermin Activity [Completed]

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer [Completed]

A Study of Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent Chemotherapy [Active, not recruiting]

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer [Active, not recruiting]

Keratinocyte Growth Factor to Prevent Autoimmunity After Alemtuzumab Treatment of Multiple Sclerosis [Recruiting]

Evaluate PKs and Efficacy Assessment of Palifermin in Patients With Sarcoma [Completed]

Effect of Palifermin on Skin Tumors in Patients Undergoing Bone Marrow Transplantation [Terminated]

Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation [Recruiting]

Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) [Active, not recruiting]

Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer [Terminated]

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation [Recruiting]

PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation [Completed]

Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Myeloma [Not yet recruiting]

Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma [Withdrawn]

Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies [Active, not recruiting]

Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants [Completed]

Recombinant Human Keratinocyte Growth Factor to Reduce Oral Mucositis in Hematologic Malignancy Patients Undergoing Peripheral Blood Stem Cell Transplantation After Radiation and High-dose Chemotherapy [Completed]

Phase 2 Haplotype Mismatched HSCT in Patients With Hematological Malignancies [Recruiting]

High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma [Active, not recruiting]

CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma [Terminated]

High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease [Active, not recruiting]

Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD [Terminated]

Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies [Completed]

A Study to Assess Safety and Efficacy of a Novel Treatment, Keratinocyte Growth Factor (KGF), in Asthmatic Patients [Recruiting]

Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer [Completed]

Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer [Completed]

Keratinocyte Growth Factor to Prevent Acute GVHD [Completed]

Standard Chemotherapy With or Without Nelarabine or Rituximab in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [Recruiting]

Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID) [Recruiting]

A Pilot Study of Efficacy of Lactobacillus CD2 Lozenges in Preventing High-dose Chemotherapy Induced Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation [Completed]

A Phase III Study of Efficacy of Lactobacillus CD2 Lozenges in Preventing High-Dose Chemotherapy Induced Oral Mucositis in Patients Undergoing Myeloablative Hematopoietic Stem Cell Transplantation [Not yet recruiting]

Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB) [Active, not recruiting]

Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID) [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017